The COVID-19 pandemic highlighted both the incredible promise and challenges for life science companies developing and manufacturing drugs, biological products, and devices that enhance our lives....more
9/25/2023
/ Biologics ,
Coronavirus/COVID-19 ,
False Statements ,
Food and Drug Administration (FDA) ,
Fraud ,
Inspections ,
Life Sciences ,
Manufacturers ,
Pharmaceutical Industry ,
Public Health ,
Warning Letters